A government-led effort to identify correlates of protection for COVID-19 vaccines.

Koup, Richard A; Donis, Ruben O; Gilbert, Peter B; Li, Andrew W; Shah, Najaf A; Houchens, Christopher R

Koup, Richard A; Donis, Ruben O; Gilbert, Peter B; Li, Andrew W; Shah, Najaf A; Houchens, Christopher R.

Koup RA; Vaccine Research Center, National Institutes of Health, Bethesda, MD, USA. rkoup@mail.nih.gov.
Donis RO; Biomedical Advanced Research and Development Authority, US Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Washington, DC, USA. ruben.donis@hhs.gov.
Gilbert PB; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA.
Li AW; Boston Consulting Group, Summit, NJ, USA.
Shah NA; Boston Consulting Group, Summit, NJ, USA.
Houchens CR; Biomedical Advanced Research and Development Authority, US Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Washington, DC, USA.

Nat Med ; 27(9): 1493-1494, 2021 09.

Article in English | MEDLINE | ID: covidwho-1406395

Subject(s)

Antibodies, Viral/blood; COVID-19 Vaccines/immunology; COVID-19/immunology; COVID-19/prevention & control; Immunogenicity, Vaccine/immunology; Humans; Population Groups/statistics & numerical data; SARS-CoV-2/immunology; Spike Glycoprotein, Coronavirus/immunology; United States

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunogenicity, Vaccine / COVID-19 Vaccines / COVID-19 / Antibodies, Viral Type of study: Randomized controlled trials Topics: Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: Nat Med Journal subject: Molecular Biology / Medicine Year: 2021 Document Type: Article Affiliation country: S41591-021-01484-6

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google